| Literature DB >> 24186889 |
Yuebing Li1, Yeeshu Arora, Kerry Levin.
Abstract
Myasthenia gravis is a prototypical antibody-mediated autoimmune neuromuscular disorder. Treatments have improved over the past 30 years, leading to significantly fewer deaths and better quality of life. Future research should further elucidate its pathogenesis, reveal better ways to diagnose it, and yield new treatments.Entities:
Mesh：
Year: 2013 PMID： 24186889 DOI： 10.3949/ccjm.80a.13044
Source DB: PubMed Journal: Cleve Clin J Med ISSN： 0891-1150 Impact factor: 2.321